IVBT Stock — Innovation1 Biotech Inc

Innovation1 Biotech Inc (IVBT)

Updated October 9, 2026.

Innovation1 Biotech Inc. is a pharmaceutical company that researches, develops, and sells supplement and medical nutrition products, including natural flu remedies and long-covid treatments under the NutraFlu and Nutravid19 brands, while advancing NLC001 through Phase II clinical trials for viral indications. The company does not currently distribute dividends to shareholders. This stock may appeal to investors seeking exposure to the biotech and healthcare sectors, though it is not suitable for those focused on generating current income.

IVBT performance

Returns are updating. IVBT's total return appears here after the next nightly update.

IVBT key facts

Asset type

Stock

Asset class

Equity

Inception date

09/22/2017

Distribution frequency

None

Last close

$0.0002 (stale; as of 2026-10-09)

Market cap

$4,494

Average volume

0.0

Payment date

01/12/2021

Payout ratio

0.0%

EPS

$-0.31

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

Who may consider IVBT — and who may not

It is a weaker fit for investors who need monthly cash flow (IVBT does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on IVBT

• All tickers starting with I

Tagged: Healthcare.

Frequently asked questions